14/05/2026
No final sterilization means no room for error.
While terminal sterilization remains the preferred method for sterility assurance, it is not feasible for many modern therapies and may damage their structure and function.
Advanced products such as mRNA, ADCs, vaccines, and cell & gene therapies are highly sensitive, requiring alternative approaches to achieve sterility without compromising product quality.
Aseptic processing becomes essential, where every stage, from pre-sterilization to final assembly, must be tightly controlled to prevent contamination.
To meet these demands, Esco GPPI is engineered to deliver a Grade A / ISO Class 5 environment, ensuring a high level of contamination control for critical processes while offering the flexibility to adapt to your facility requirements.
Download the brochure to explore Esco GPPI in detail:
https://www.escopharma.com/pdf/brochures/general-processing-platform-isolator-GPPI-brochure